Explore More Than Just This Free Article

This article is a glimpse of the exclusive insights we provide daily to industry leaders. Dive deeper into our industry-specific reports and uncover the strategic information you need.

Industry Intelligence needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.

BASF to end production of adipic acid, cyclododecanone and cyclopentanone at Ludwigshafen site in Germany; closures planned for 2025 as part of strategic review to improve site profitability

August 29, 2024 (press release) –

  • Measures aim to improve profitability of the Ludwigshafen site
  • Closures to be implemented in 2025; affected employees will be supported in finding new employment opportunities

BASF will end the production of adipic acid, cyclododecanone (CDon) and cyclopentanone (CPon) at the Ludwigshafen site. The production plant for CDon and CPon will be shut down in the first half of 2025 and the remaining adipic acid production in Ludwigshafen will be closed in the course of 2025. The company has taken this decision as part of the ongoing strategic review of its production setup at the Ludwigshafen site to ensure competitiveness under changing market conditions.

The production capacity for adipic acid had already been reduced as part of the adjustments to the Verbund structures at the Ludwigshafen site announced in February 2023. The remaining adipic acid production was partially continued to ensure supplies of raw materials for the production of CDon and CPon. BASF will cease deliveries of CDon and CPon in close coordination with customers.

Approximately 180 employees will be affected by the plant closures. BASF will support affected employees in finding new employment opportunities within the BASF Group.

“BASF is taking this step to ensure profitability across the Verbund value chains by adjusting production structures to changed market conditions. We will be in close contact with our customers to minimize the impact of the closures,” explains Dr. Stephan Kothrade, Member of the Board of Executive Directors and Chief Technology Officer of BASF SE. “We will continue to produce adipic acid in Onsan, South Korea, as well as in our joint venture in Chalampé, France.”

“These closures are part of the development of a long-term target picture for the transformation of the Ludwigshafen site,” says Dr. Katja Scharpwinkel, Member of the Board of Executive Directors, Industrial Relations Director of BASF SE and Director of the Ludwigshafen Site. “We support our affected colleagues to quickly find new opportunities in BASF.”

CDon is the main raw material to produce lauryl lactam, a precursor for the high-performance plastic polyamide 12 (PA 12). CDon is also used in the synthesis of musk fragrances and UV stabilizers. CPon is used as a building block for synthesizing crop protection agents and active pharmaceutical ingredients, as a solvent in the manufacture of semiconductors, and as a precursor to producing special fragrances. Adipic acid is used to produce polyamides, polyurethanes, coatings, and adhesives, among other things.

About BASF

At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. Around 112,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €68.9 billion in 2023. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States. Further information at www.basf.com.

P-24-269

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo with Jason
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order chemicals industry coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy. We won't track your information when you visit our site. But in order to comply with your preferences, we'll have to use just one tiny cookie so that you're not asked to make this choice again.